Gene Therapy in Treating Patients With Recurrent or Progressive Glioblastoma Multiforme - Contacts and Locations

Gene Therapy in Treating Patients With Recurrent or Progressive Glioblastoma Multiforme

This study is ongoing, but not recruiting participants.

Study NCT00036725. Last updated on July 23, 2008. Information provided by National Cancer Institute (NCI)

Please refer to this study by its ClinicalTrials.gov identifier: NCT00036725

Locations


United States, Alabama
	University of Alabama at Birmingham Comprehensive Cancer Center
	Birmingham, Alabama, United States, 35294-3300

United States, Arizona
	Arizona Cancer Center at University of Arizona Health Sciences Center
	Tucson, Arizona, United States, 85724

United States, California
	UCSF Comprehensive Cancer Center
	San Francisco, California, United States, 94115

United States, Colorado
	University of Colorado Cancer Center at University of Colorado Health Sciences Center
	Denver, Colorado, United States, 80262

United States, Massachusetts
	Massachusetts General Hospital Cancer Center
	Boston, Massachusetts, United States, 02114

United States, Pennsylvania
	Abramson Cancer Center at University of Pennsylvania Medical Center
	Philadelphia, Pennsylvania, United States, 19104-4283

Sponsors and Collaborators

Biogen Idec

Investigators


Study Chair:	Steven S. Rosenfeld, MD, PhD	Lurleen Wallace Comprehensive Cancer at University of Alabama-Birmingham